Zymeworks Inc.
ZYME:NYSE; ZYME:TSX
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. The company's suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.
Streetwise Company Fact Sheet2025/9/16 20:01:53
(ZYME:NYSE - ZYME:TSX)
Analyst coverage
| H.C. Wainwright & Co. — Dr. Ram Selvaraju |
Streetwise Reports Articles
| 09/25/2024 - View Article |
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
